×

NDS ZeroWire Mobile - Improving Clinical Ergonomics With Cordless Mobility by Ampronix

ORANGE COUNTY, Calif., Oct. 10, 2017 /PRNewswire/ -- NDS received FDA 510(k) clearance in May 2017 for its highly anticipated ZeroWire® Mobile — a medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile aims to transform technology into a clinical solution to support the improvement of patient outcomes, procedural efficiency, and the lowering of operational costs.

Innovative Design

By removing display cables, ZeroWire Mobile helps eliminate tripping hazards and permits the untethered mobility of endoscopy displays. An additional feature is the small wheel base of ZeroWire Mobile which offers flexible positioning in tight spaces. Once situated, the wheels can be locked into place for secure disposition. The monitor on a ZeroWire Mobile stand can also be relocated from room to room and efficiently paired with a wireless video transmitter, potentially expediting turnaround times.

The device can be used in tandem with the ZeroWire G2 external wireless HD video transmission platform, compatible with both medical and non-medical devices. ZeroWire G2 utilizes a point-to-point tracking system that locks the transmitter and receiver together, avoiding signal loss when moved.

The ZeroWire Mobile display stand supports two sealed and cleanable power modules. When a power module is running low, LED light bars and an audible alarm will indicate when it is time for a replacement. The batteries can be easily exchanged or "hot-swapped" with fresh power modules from the wall-mounted charging system in cases of extended operation. With two fully charged power modules, ZeroWire Mobile can power an NDS 32-inch monitor for up to five hours of continuous operation.

"We are driven to innovate new technologies that give clinical teams the flexibility, ease-of-use, and efficiencies they are looking for in critical care applications," said Darko Spoljaric, Vice President of Global Marketing at NDS. "ZeroWire Mobile is designed specifically for the endoscopic environment, with a view to providing a medical-grade, highly mobile imaging solution."

Michael Thomas, Director of Marketing at Ampronix, is impressed with the innovative technology NDS has created, stating, "The seamless combination of wireless connectivity and versatility in movement make ZeroWire Mobile a great addition to any operating or procedure room."

About NDS

Headquartered in Silicon Valley, CA, NDS is a global leader in designing and manufacturing endoscopy visualization, video processing, and wireless imaging systems. NDS technology solutions have led the way in re-defining modern operating rooms and endoscopy suites.

At the forefront of innovation in medical imaging technology, NDS delivers HD and 4K UHD visualization products that enable the clinical imaging solutions of the future, and drive constant improvements in collaborative medicine. NDS, a Novanta Company, has U.S.-based R&D and manufacturing facilities, and a global presence in more than 35 countries.

About Ampronix

Ampronix is a renowned authorized master distributor of the medical industry's top brands as well as a world-class manufacturer of innovative technology. Since 1982, Ampronix has been dedicated to meeting the growing needs of the medical community with its extensive product knowledge, outstanding service, and state-of-the-art repair facility. Ampronix prides itself on its ability to offer tailored, one-stop solutions at a faster and more cost-effective rate than other manufacturers. Ampronix is ISO 13485:2003, ISO 9001:2008, and ANSI/ESD S20.20-2014 certified.

To learn more about NDS and Ampronix, please contact Mr. Thomas at 800-400-7972. He can also be reached via email at mthomas@ampronix.com.

Related Video

http://www.youtube.com/watch?v=U5rqVYdyQQ0

View original content with multimedia:http://www.prnewswire.com/news-releases/nds-zerowire-mobile---improving-clinical-ergonomics-with-cordless-mobility-by-ampronix-300533928.html

SOURCE Ampronix